Tubulis GmbH’s Post

View organization page for Tubulis GmbH, graphic

4,868 followers

Meet our #clinical development team at the upcoming #ASCO24 conference from May 31 to June 4, 2024, in #Chicago! Are you interested to learn more about our proprietary suite of unique #ADC technologies and target #SolidTumor indications, want to deep-dive into our promising efficacy & safety data for lead candidates TUB-030 and TUB-040, or get an introduction to the designs and protocol requirements of our soon-to-start #ClinicalTrials? Join us at our #booth 27123 in exhibition hall A to learn more and have a chat with our on-site team: Günter Fingerle-Rowson, CMO, Bjoern Hock, CDO, Mary Ann Lumiqued, VP Program Management, giovanni selvaggi, Consultant Clinical Development, and Inês Vasconcelos, Medical Director. If you’d like to book a 1:1 meeting with us, please use the following link: https://bit.ly/3UUmZOj Not in Chicago? Learn more about our revolutionary approach to usher in a new ADC era for better #patient outcomes at www.tubulis.com.

Bjoern M Hock

Founder and CEO, Lavaux Biotech consulting; CDO Tubulis GmbH

2mo

I am excited representing Tubulis at ASCO together with my great colleagues

Andreas Wallnoefer

Partner at Jeito Capital Investor and Board Director in Biotech

2mo

Tubulis GmbH and Dominik Schumacher : Top company and team All success !

See more comments

To view or add a comment, sign in

Explore topics